Who Paid My Doc
Isadore Rubin
Developmental - Behavioral Pediatrics Atlanta, GA Medical Doctor
NPI 1710987920 CMS profile 554576
35 Jesse Hill Jr Dr Se, Hughes Spalding Childrens Hospital, Atlanta, GA 30303
General payments
$14
Research payments
$0
Ownership & investment interest
$0
Through program year 2021, Isadore Rubin of Atlanta, GA is reported in the CMS Open Payments database as having received $14 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 6th percentile of Developmental - Behavioral Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2021 | General | $14 | 1 |
Beside peers
- Isadore Rubin
- Developmental - Behavioral Pediatrics median
- Middle half of Developmental - Behavioral Pediatrics
- National median
In program year 2025, general payments to Isadore Rubin were reported at $0. Among 160 Developmental - Behavioral Pediatrics profiles paid that year, the median was $77 and the middle half received between $27 and $211.
Show as a table
| Year | Isadore Rubin | Developmental - Behavioral Pediatrics median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $106 | $28–$315 | $163 |
| 2020 | $0 | $55 | $19–$181 | $114 |
| 2021 | $14 | $96 | $25–$343 | $132 |
| 2022 | $0 | $86 | $23–$235 | $149 |
| 2023 | $0 | $71 | $25–$348 | $160 |
| 2024 | $0 | $74 | $25–$237 | $164 |
| 2025 | $0 | $77 | $27–$211 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 2 drugsPart D claims
28
Drug cost
$493
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Divalproex Sodium | Generic | 12 | $400 | |
| Sertraline Hcl | Generic | 16 | $93 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,361 Part D prescribers listed as Pediatric Medicine; they describe a distribution and say nothing about conduct.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Developmental - Behavioral Pediatrics in Georgia
Alan Weintraub
Developmental - Behavioral Pediatrics · Norcross, GA
Jack Miller
Developmental - Behavioral Pediatrics · Carrollton, GA
Doris Greenberg
Developmental - Behavioral Pediatrics · Savannah, GA
Sonia George
Developmental - Behavioral Pediatrics · Marietta, GA
Rachel Goodson
Developmental - Behavioral Pediatrics · Macon, GA
Elizabeth Young
Developmental - Behavioral Pediatrics · Macon, GA
Related records
Developmental - Behavioral Pediatrics in Georgia
Practitioners in the same specialty and state, ranked by reported value.
All Developmental - Behavioral Pediatrics
Everyone recorded under this specialty, nationwide.
Doctors in Georgia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.